(Q73599577)

English

Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study

scientific article published on 01 April 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

based on heuristic

inferred from title

Jean-Marc Virion

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

M Echemann

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

F Zannad

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Briançon

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Y Juillière

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P M Mertès

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J P Villemot

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

0 references

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

139

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

624-631

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

The place of angiotensin-converting enzyme inhibition in the treatment of cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

A cardiologist's perspective on evolving concepts in the management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Medical treatment of end-stage heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

The management of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Current guidelines for the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Current controversies with ACE inhibitor treatment in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Improving survival for patients with advanced heart failure: A study of 737 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Survey on heart failure in Italian hospital cardiology units. Results of the SEOSI study. SEOSI Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Association between diuretic use, clinical response, and death in acute heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Angiotensin-converting enzyme inhibitor and spironolactone combination therapy. New objectives in congestive heart failure treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990039-5

7 January 2021

Identifiers

10.1016/S0002-8703(00)90039-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740143%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73599577&oldid=1754012003"